ReviewOpen medicine (Warsaw, Poland)2025
The maternal factors during pregnancy for intrauterine growth retardation: An umbrella review.
Review in Open medicine (Warsaw, Poland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: There is no umbrella review on maternal risk factors associated with intrauterine growth retardation (IUGR). Therefore, we assessed an umbrella review on maternal risk factors during pregnancy for IUGR. Methods: We searched three prominent international databases: PubMed, Scopus, Web of Science, and Cochrane Library. We focused on meta-analyses that examined maternal factors during pregnancy associated with IUGR. The comparison was based on the odds ratio (OR) or related risk ratios reported in the included studies, heterogeneity Results: Four risk factors for IUGR include placenta previa with an OR of 1.19, placenta abruption with an OR of 2.06, epilepsy in pregnancy with an OR of 1.28, and hepatitis C virus (HCV) infection with an OR of 1.53 were categorized as having suggestive evidence (Class III). Celiac disease with an OR of 2.48 and mullerian anomaly with an OR of 1.93 were considered risk factors with weak evidence (Class IV). Conclusion: Four risk factors for IUGR including placenta previa, placenta abruption, epilepsy in pregnancy, and HCV infection were categorized as having suggestive evidence (Class III). Celiac disease and Mullerian anomaly were considered risk factors with weak evidence (Class IV).
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.